Intuitive Surgical, Inc. $ISRG Shares Sold by Purus Wealth Management LLC

Purus Wealth Management LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,683 shares of the medical equipment provider’s stock after selling 1,614 shares during the period. Intuitive Surgical makes up about 4.2% of Purus Wealth Management LLC’s investment portfolio, making the stock its 5th biggest holding. Purus Wealth Management LLC’s holdings in Intuitive Surgical were worth $13,413,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after acquiring an additional 263,828 shares in the last quarter. Capital World Investors grew its stake in shares of Intuitive Surgical by 1.5% during the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after acquiring an additional 116,034 shares in the last quarter. Fisher Asset Management LLC grew its stake in shares of Intuitive Surgical by 1.1% during the third quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider’s stock valued at $1,739,475,000 after acquiring an additional 40,702 shares in the last quarter. Amundi grew its stake in shares of Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares in the last quarter. Finally, Legal & General Group Plc grew its stake in shares of Intuitive Surgical by 6.3% during the third quarter. Legal & General Group Plc now owns 2,376,714 shares of the medical equipment provider’s stock valued at $1,062,938,000 after acquiring an additional 141,357 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on ISRG shares. BTIG Research restated a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a research note on Friday, April 10th. The Goldman Sachs Group lowered their target price on Intuitive Surgical from $714.00 to $609.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, HSBC raised their target price on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $598.36.

Intuitive Surgical Stock Down 0.8%

Shares of NASDAQ ISRG opened at $465.60 on Tuesday. The firm’s 50-day moving average price is $478.67 and its two-hundred day moving average price is $515.64. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88. The stock has a market capitalization of $165.35 billion, a P/E ratio of 59.01, a P/E/G ratio of 3.66 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.21 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.16 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.